SS
IMMX icon

SBI Securities’s Immix Biopharma IMMX Stock Holding History

SBI Securities’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103K Hold
10,000
– – ﹤0.01% 906
2026
Q1 		$91.1K Hold
10,000
– – ﹤0.01% 880
2025
Q4 		$52.3K Sell
10,000
-7,500
-43% -$30.9K ﹤0.01% 1067
2025
Q3 		$36.6K Hold
17,500
– – ﹤0.01% 1205
2025
Q2 		$36.2K Hold
17,500
– – ﹤0.01% 1177
2025
Q1 		$29.4K Hold
17,500
– – ﹤0.01% 1182
2024
Q4 		$38.5K Buy
+17,500
New +$32K ﹤0.01% 1062

Other funds holding IMMX

IFWM
Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
C
Certuity North Palm Beach, Florida $2.03B AUM 88.59% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

SBI Securities's IMMX Position: Q2 2026 in Review

SBI Securities held its Immix Biopharma (IMMX) position steady in Q2 2026 at 10,000 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #906.

SBI Securities first reported a position in IMMX in Q4 2024 and has held it in 7 quarters since. 12 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • SBI Securities held 10,000 shares of Immix Biopharma worth $103K as of Q2 2026.
  • SBI Securities left its Immix Biopharma share count unchanged in Q2 2026.
  • Immix Biopharma made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #906 holding.
  • SBI Securities first reported a position in Immix Biopharma in Q4 2024 and has held it in 7 quarters since.
  • 12 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.